We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Program Encourages Wide Distribution of Genomic Data

By LabMedica International staff writers
Posted on 28 Oct 2014
A new data sharing program allows genomics researchers and practitioners to analyze, visualize, and share raw sequence data for individual patients or across populations straight from a local browser.

The sequencing revolution is providing the raw data required to identify the genetic variants underlying rare diseases and complex traits alike. More...
The NextCODE (Cambridge, MA, USA) Exchange was designed to meet the next challenge: it links the researcher to a proven sequence analysis platform and enables secure and seamless collaboration and validation of findings with colleagues and institutions around the world.

The Exchange is powered by NextCODE’s unique GOR informatics system. Optimized on whole-genome data from 350,000 people, it standardizes, manages, and queries massive sequence data with unrivalled computational efficiency. The user can visualize aligned raw sequences and collaborate and share data—in full compliance with individually established rules and consents, without transferring big files, straight from a local browser.

"The genomics community is now generating the sequence data to solve more rare disease cases and find high-impact variants in complex traits. The ability to visually confirm findings in raw sequence at a click, and to validate findings by securely sharing data with other researchers working on the same diseases elsewhere, will help to crack more difficult diagnostic cases and speed discovery. We have a fantastic group of launch partners, global leaders in rare disease and autism research, who will be able to use and demonstrate the Exchange's scalability and reach," said Dr. Jeffrey Gulcher, president and CSO of NextCODE.

Related Links:

NEXTCOODE
NEXTCODE Video



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
HPV Molecular Test
BD Onclarity HPV Assay
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.